Order for rapid identification of mutations associated with drug resistance for M. tuberculosis treatment. For phenotypic drug susceptibility testing, refer to Antimicrobial Susceptibility, AFB/Mycobacterium tuberculosis Primary Panel (0060347).
- Patient Preparation
- Collect
- Pure culture of M. tuberculosis complex on solid or liquid media.
- Specimen Preparation
- Transport sealed container with pure culture on solid or in liquid media. Place each specimen in an individually sealed bag.
- Storage/Transport Temperature
- Room temperature. If culture is suspected of being a microorganism listed as infectious substance affecting humans on IATA list, submit specimen
according to Biological Substance, Category A, shipping guidelines. - Unacceptable Conditions
- Mixed cultures, isolates other than M. tuberculosis complex, non-viable organism. Agar Plates.
- Remarks
- Organism identification required.
- Stability
- Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: Unacceptable
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2011714 | TB Rifampin Resistance by Sequencing | 48176-2 |
2011715 | TB Isoniazid Resistance by Sequencing | 48175-4 |
2011716 | TB Ethambutol Resistance by Sequencing | 46247-3 |
- AFB primary panel
- Ethambutol susceptibility
- isoniazid susceptibility
- pyrazinamide susceptibility
- rifampin susceptibility